These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID; Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135 [TBL] [Abstract][Full Text] [Related]
5. Safety and application of induced sputum analysis in childhood asthma. Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559 [TBL] [Abstract][Full Text] [Related]
6. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Petsky HL; Li A; Chang AB Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221 [TBL] [Abstract][Full Text] [Related]
7. Association of eosinophilic inflammation with FKBP51 expression in sputum cells in asthma. Tajiri T; Matsumoto H; Niimi A; Ito I; Oguma T; Nakaji H; Inoue H; Iwata T; Nagasaki T; Kanemitsu Y; Petrova G; Mishima M PLoS One; 2013; 8(6):e65284. PubMed ID: 23762334 [TBL] [Abstract][Full Text] [Related]
8. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma. Li AM; Tsang TW; Lam HS; Sung RY; Chang AB Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863 [TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641 [TBL] [Abstract][Full Text] [Related]
10. Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma? Tsujino I; Nishimura M; Kamachi A; Makita H; Munakata M; Miyamoto K; Kawakami Y Respiration; 2000; 67(6):645-51. PubMed ID: 11124647 [TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroid dose response in asthma: Should we measure inflammation? Anderson WJ; Short PM; Jabbal S; Lipworth BJ Ann Allergy Asthma Immunol; 2017 Feb; 118(2):179-185. PubMed ID: 28065396 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma. Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396 [TBL] [Abstract][Full Text] [Related]
13. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic? Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924 [TBL] [Abstract][Full Text] [Related]
14. A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial. Hanratty CE; Matthews JG; Arron JR; Choy DF; Pavord ID; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Djukanovic R; Gallagher N; Fowler SJ; Hardman TC; Harrison T; Holweg CT; Howarth PH; Lordan J; Mansur AH; Menzies-Gow A; Mosesova S; Niven RM; Robinson DS; Shaw DE; Walker S; Woodcock A; Heaney LG; Trials; 2018 Jan; 19(1):5. PubMed ID: 29301585 [TBL] [Abstract][Full Text] [Related]
15. Lung clearance index and steroid response in pediatric severe asthma. Irving S; Fleming L; Ahmad F; Biggart E; Bingham Y; Cook J; Hall P; Jamalzadeh A; Nagakumar P; Bossley C; Gupta A; Macleod K; Saglani S; Bush A Pediatr Pulmonol; 2020 Apr; 55(4):890-898. PubMed ID: 32027471 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Meijer RJ; Postma DS; Kauffman HF; Arends LR; Koëter GH; Kerstjens HA Clin Exp Allergy; 2002 Jul; 32(7):1096-103. PubMed ID: 12100060 [TBL] [Abstract][Full Text] [Related]
17. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation. Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293 [TBL] [Abstract][Full Text] [Related]
18. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids. Yin SS; Liu H; Gao X Int J Clin Pharmacol Ther; 2017 Jan; 55(1):66-77. PubMed ID: 27443657 [TBL] [Abstract][Full Text] [Related]
19. Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features. Fitzpatrick AM; Stephenson ST; Brown MR; Nguyen K; Douglas S; Brown LAS J Allergy Clin Immunol Pract; 2017; 5(2):410-419.e4. PubMed ID: 27665382 [TBL] [Abstract][Full Text] [Related]
20. Comparison of exhaled nitric oxide to spirometry during emergency treatment of asthma exacerbations with glucocorticoids in children. Lanz MJ; Leung DY; White CW Ann Allergy Asthma Immunol; 1999 Feb; 82(2):161-4. PubMed ID: 10071519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]